6-Bromo-2,4-dichlorofuro[3,2-d]pyrimidine is a heterocyclic compound characterized by its fused ring structure, which incorporates both furan and pyrimidine moieties. This compound features bromine and chlorine substituents, which can significantly influence its chemical reactivity and biological activity. The presence of halogens often enhances lipophilicity and can affect the compound's interaction with biological targets, making it of interest in medicinal chemistry. Its molecular structure suggests potential applications in pharmaceuticals, particularly in the development of compounds with antimicrobial or anticancer properties. The compound's unique arrangement of atoms contributes to its electronic properties, which can be studied using various spectroscopic techniques. Additionally, the presence of multiple halogen atoms may impart stability against metabolic degradation, making it a candidate for further research in drug development. As with many halogenated compounds, safety and environmental considerations are essential, as they may exhibit toxicity or persistence in biological systems.

6-bromo-2,4-dichlorofuro[3,2-d]pyrimidine

1363382-31-3: 6-Bromo-2,4-dichlorofuro[3,2-d]pyrimidine is a heterocyclic compound characterized by its fused ring structure, which incorporates both furan and pyrimidine moieties. This compound features bromine and chlorine substituents, which can significantly influence its chemical reactivity and biological activity. The presence of halogens often enhances lipophilicity and can affect the compound's interaction with biological targets, making it of interest in medicinal chemistry. Its molecular structure suggests potential applications in pharmaceuticals, particularly in the development of compounds with antimicrobial or anticancer properties. The compound's unique arrangement of atoms contributes to its electronic properties, which can be studied using various spectroscopic techniques. Additionally, the presence of multiple halogen atoms may impart stability against metabolic degradation, making it a candidate for further research in drug development. As with many halogenated compounds, safety and environmental considerations are essential, as they may exhibit toxicity or persistence in biological systems.

CAS 1363382-31-3

6-bromo-2,4-dichlorofuro[3,2-d]pyrimidine

6-Bromo-2,4-dichlorofuro[3,2-d]pyrimidine

Ref: IN-DA0011PX

6-BROMO-2,4-DICHLOROFURO[3,2-D]PYRIMIDINE

Ref: 10-F502993